Articles
Enhanced external counterpulsation: A unique treatment for the “No-Option” refractory angina patient
Enhanced external counterpulsation: A unique treatment for the “No-Option” refractory angina patient
The Role of Enhanced External Counter Pulsation Therapy in Clinical Practice
Enhanced external counterpulsation (EECP) has been approved by the United States Food and Drug Administration (FDA) for management of refractory angina (Class IIb). Article by PubMed.
Effect of enhanced external counterpulsation versus individual shear rate therapy on the peripheral artery functions
Effect of enhanced external counterpulsation versus individual shear rate therapy on the peripheral artery functions. Article by nature.com and science reports.